128 related articles for article (PubMed ID: 38204433)
1. A review on recent advances in assays for DNMT1: a promising diagnostic biomarker for multiple human cancers.
Yu Y; Fu W; Xie Y; Jiang X; Wang H; Yang X
Analyst; 2024 Feb; 149(4):1002-1021. PubMed ID: 38204433
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
3. DNMT1: catalytic and non-catalytic roles in different biological processes.
Mohan KN
Epigenomics; 2022 May; 14(10):629-643. PubMed ID: 35410490
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.
Suzuki M; Sunaga N; Shames DS; Toyooka S; Gazdar AF; Minna JD
Cancer Res; 2004 May; 64(9):3137-43. PubMed ID: 15126351
[TBL] [Abstract][Full Text] [Related]
5. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer.
He S; Wang F; Yang L; Guo C; Wan R; Ke A; Xu L; Hu G; Xu X; Shen J; Wang X
PLoS One; 2011; 6(11):e27684. PubMed ID: 22110720
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin prevents BMP-2 driven cell migration and invasion by suppressing oncogenic DNMT1 expression in breast cancer cells.
Yadav P; Bandyopadhayaya S; Soni S; Saini S; Sharma LK; Shrivastava SK; Mandal CC
Gene; 2023 Oct; 882():147636. PubMed ID: 37442305
[TBL] [Abstract][Full Text] [Related]
7. CpG methylation is maintained in human cancer cells lacking DNMT1.
Rhee I; Jair KW; Yen RW; Lengauer C; Herman JG; Kinzler KW; Vogelstein B; Baylin SB; Schuebel KE
Nature; 2000 Apr; 404(6781):1003-7. PubMed ID: 10801130
[TBL] [Abstract][Full Text] [Related]
8. Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.
Motawi TK; El-Maraghy SA; Sabry D; Nady OM; Senousy MA
Chem Biol Interact; 2022 Sep; 365():110094. PubMed ID: 35961540
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis.
Yu Z; Xiao Q; Zhao L; Ren J; Bai X; Sun M; Wu H; Liu X; Song Z; Yan Y; Mi X; Wang E; Jin F; Wei M
Mol Carcinog; 2015 Sep; 54(9):707-19. PubMed ID: 24464625
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors.
Li A; Omura N; Hong SM; Goggins M
Cancer Biol Ther; 2010 Feb; 9(4):321-9. PubMed ID: 20234167
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
Jahangiri R; Jamialahmadi K; Gharib M; Emami Razavi A; Mosaffa F
Gene; 2019 Feb; 685():24-31. PubMed ID: 30359738
[TBL] [Abstract][Full Text] [Related]
12. Enhanced processivity of Dnmt1 by monoubiquitinated histone H3.
Mishima Y; Brueckner L; Takahashi S; Kawakami T; Otani J; Shinohara A; Takeshita K; Garvilles RG; Watanabe M; Sakai N; Takeshima H; Nachtegael C; Nishiyama A; Nakanishi M; Arita K; Nakashima K; Hojo H; Suetake I
Genes Cells; 2020 Jan; 25(1):22-32. PubMed ID: 31680384
[TBL] [Abstract][Full Text] [Related]
13. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
Varol N; Konac E; Bilen CY
Exp Biol Med (Maywood); 2015 May; 240(5):624-30. PubMed ID: 25349215
[TBL] [Abstract][Full Text] [Related]
14. Role of Mammalian DNA Methyltransferases in Development.
Chen Z; Zhang Y
Annu Rev Biochem; 2020 Jun; 89():135-158. PubMed ID: 31815535
[TBL] [Abstract][Full Text] [Related]
15. DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis.
Pathania R; Ramachandran S; Elangovan S; Padia R; Yang P; Cinghu S; Veeranan-Karmegam R; Arjunan P; Gnana-Prakasam JP; Sadanand F; Pei L; Chang CS; Choi JH; Shi H; Manicassamy S; Prasad PD; Sharma S; Ganapathy V; Jothi R; Thangaraju M
Nat Commun; 2015 Apr; 6():6910. PubMed ID: 25908435
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors.
Honeywell RJ; Sarkisjan D; Kristensen MH; de Klerk DJ; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2018; 37(12):696-708. PubMed ID: 30663502
[TBL] [Abstract][Full Text] [Related]
17. The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent.
Brenner C; Luciani J; Bizet M; Ndlovu M; Josseaux E; Dedeurwaerder S; Calonne E; Putmans P; Cartron PF; Defrance M; Fuks F; Deplus R
Oncotarget; 2016 Sep; 7(37):58939-58952. PubMed ID: 27449289
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
[TBL] [Abstract][Full Text] [Related]
20. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells.
Zhang Y; Chen FQ; Sun YH; Zhou SY; Li TY; Chen R
J Exp Clin Cancer Res; 2011 Oct; 30(1):98. PubMed ID: 21999220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
